MCKENZIE DIANA — SEC insider filings

SEC reporting owner CIK 1754648. 80 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers the 50 most recent of 80 filings on record, filed 2022-10-05 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
agilon health, inc. (AGL)Director62 legs · 20,000 sh · $44,962—6
METLIFE INC (MET)Director34——34
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director10——18

Insider filings — MCKENZIE DIANA

FiledFormIssuerReported transactionsSource
2026-10-054METLIFE INC (MET)Grant/award (A): 544 @ $94.35EDGAR
2026-09-104METLIFE INC (MET)Grant/award (A): 157 @ $95.50EDGAR
2026-06-184METLIFE INC (MET)Grant/award (A): 587 @ $87.40EDGAR
2026-06-114METLIFE INC (MET)Grant/award (A): 169 @ $85.57EDGAR
2026-06-044agilon health, inc. (AGL)Grant/award (A): 2,133 @ $0EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 943 @ $0 · Disposition to issuer (D): 796 · Grant/award (A): 796 (derivative)EDGAR
2026-04-034METLIFE INC (MET)Grant/award (A): 721 @ $71.17EDGAR
2026-03-124METLIFE INC (MET)Grant/award (A): 189 @ $70.60EDGAR
2026-01-064METLIFE INC (MET)Grant/award (A): 639 @ $80.32EDGAR
2025-12-114METLIFE INC (MET)Grant/award (A): 166 @ $77.82EDGAR
2025-10-034METLIFE INC (MET)Grant/award (A): 534 @ $81.93EDGAR
2025-09-114METLIFE INC (MET)Grant/award (A): 158 @ $79.29EDGAR
2025-06-204METLIFE INC (MET)Grant/award (A): 562 @ $77.85EDGAR
2025-06-124METLIFE INC (MET)Grant/award (A): 153 @ $79.43EDGAR
2025-05-304agilon health, inc. (AGL)Grant/award (A): 78,724 @ $0EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 796 @ $0 · Disposition to issuer (D): 1,001 · Grant/award (A): 1,001 (derivative)EDGAR
2025-04-034METLIFE INC (MET)Grant/award (A): 540 @ $81.16EDGAR
2025-03-134METLIFE INC (MET)Grant/award (A): 144 @ $78.45EDGAR
2025-01-064METLIFE INC (MET)Grant/award (A): 535 @ $81.78EDGAR
2024-12-184METLIFE INC (MET)Grant/award (A): 132 @ $82.74EDGAR
2024-12-114agilon health, inc. (AGL)Purchase (P): 12,500 @ $2.28 · Purchase (P): 7,500 @ $2.20EDGAR
2024-10-034METLIFE INC (MET)Grant/award (A): 535 @ $81.78EDGAR
2024-09-124METLIFE INC (MET)Grant/award (A): 141 @ $74.63EDGAR
2024-06-204METLIFE INC (MET)Grant/award (A): 627 @ $69.86EDGAR
2024-06-134METLIFE INC (MET)Grant/award (A): 146 @ $69.06EDGAR
2024-05-314agilon health, inc. (AGL)Grant/award (A): 32,119 @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,001 @ $0 · Disposition to issuer (D): 1,168 · Grant/award (A): 1,168 (derivative)EDGAR
2024-04-034METLIFE INC (MET)Grant/award (A): 594 @ $73.69EDGAR
2024-03-184METLIFE INC (MET)Grant/award (A): 129 @ $71.90EDGAR
2024-01-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 76.50 (derivative) @ $432.99EDGAR
2024-01-044METLIFE INC (MET)Grant/award (A): 650 @ $67.35EDGAR
2023-12-184METLIFE INC (MET)Grant/award (A): 132 @ $66.90EDGAR
2023-10-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 89.53 (derivative) @ $369.98EDGAR
2023-10-044METLIFE INC (MET)Grant/award (A): 710 @ $61.69EDGAR
2023-09-184METLIFE INC (MET)Grant/award (A): 128 @ $65.93EDGAR
2023-07-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 89.93 (derivative) @ $350.79EDGAR
2023-06-224METLIFE INC (MET)Grant/award (A): 803 @ $54.52EDGAR
2023-06-164METLIFE INC (MET)Grant/award (A): 147 @ $53.94EDGAR
2023-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Disposition to issuer (D): 1,449 · Grant/award (A): 1,168 @ $0 · Grant/award (A): 1,449 (derivative)EDGAR
2023-04-184agilon health, inc. (AGL)Grant/award (A): 5,622 @ $0EDGAR
2023-04-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 90.15 (derivative) @ $332.77EDGAR
2023-04-054METLIFE INC (MET)Grant/award (A): 755 @ $57.97EDGAR
2023-03-164METLIFE INC (MET)Grant/award (A): 121 @ $59.07EDGAR
2023-03-024METLIFE INC (MET)Grant/award (A): 31 @ $71.73EDGAR
2023-02-224agilon health, inc. (AGL)Grant/award (A): 1,078 @ $0 · Grant/award (A): 11,104 (derivative) @ $0EDGAR
2023-01-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 100.53 (derivative) @ $298.42EDGAR
2023-01-054METLIFE INC (MET)Grant/award (A): 520 @ $72.15EDGAR
2022-12-164METLIFE INC (MET)Grant/award (A): 94 @ $72.84EDGAR
2022-10-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 101.07 (derivative) @ $296.82EDGAR
2022-10-054METLIFE INC (MET)Grant/award (A): 599 @ $62.62EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs